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a b s t r a c t
Mammalian aldehyde dehydrogenase 7A1 (ALDH7A1) is homologous to plant ALDH7B1 which protects
against various forms of stress such as increased salinity, dehydration and treatment with oxidants or pes-
ticides. Deleterious mutations in human ALDH7A1 are responsible for pyridoxine-dependent and folinic
acid-responsive seizures. In previous studies, we have shown that human ALDH7A1 protects against
hyperosmotic stress presumably through the generation of betaine, an important cellular osmolyte,
formed from betaine aldehyde. Hyperosmotic stress is coupled to an increase in oxidative stress and lipid
peroxidation (LPO). In this study, cell viability assays revealed that stable expression of mitochondrial
ALDH7A1 in Chinese hamster ovary (CHO) cells provides significant protection against treatment with
the LPO-derived aldehydes hexanal and 4-hydroxy-2-nonenal (4HNE) implicating a protective function
for the enzyme during oxidative stress. A significant increase in cell survival was also observed in CHO
cells expressing either mitochondrial or cytosolic ALDH7A1 treated with increasing concentrations of
hydrogen peroxide (H2O2) or 4HNE, providing further evidence for anti-oxidant activity. In vitro enzyme
activity assays indicate that human ALDH7A1 is sensitive to oxidation and that efficiency can be at least
partially restored by incubating recombinant protein with the thiol reducing agent -mercaptoethanol
(BME). We also show that after reactivation with BME, recombinant ALDH7A1 is capable of metabolizing
the reactive aldehyde 4HNE. In conclusion, ALDH7A1 mechanistically appears to provide cells protection
through multiple pathways including the removal of toxic LPO-derived aldehydes in addition to osmolyte
generation.
. Introduction
Aldehyde dehydrogenases facilitate the NAD(P)+ dependent
xidation of aldehydes to their corresponding carboxylic acids
nd NAD(P)H. These enzymes participate in many physiologi-
ally important biosynthetic pathways but also play a crucial
ole in removing toxic aldehydes produced during oxidative
tress and the metabolism of xenobiotics. Aldehyde dehydro-
enase 7A1 (ALDH7A1), originally named antiquitin, was first
dentified in plants as an enzyme that was upregulated during
arious insults such as increased salinity, dehydration and treat-
ent with oxidants or pesticides [1–4]. Deleterious mutations in
Abbreviations: AASA, -aminoadipic semialdehyde; 4HNE, 4-hydroxy-2-
onenal; ALDH7A1, aldehyde dehydrogenase 7A1; BME, -mercaptoethanol; CHO,
hinese hamster ovary; DTT, dithiothreitol; H2O2, hydrogen peroxide; LPO, lipid
eroxidation; MDA, malondialdehyde; ROS, reactive oxygen species.
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human ALDH7A1 cause pyridoxine-dependent and folinic acid-
responsive seizures [5,6]. In mammals, ALDH7A1 plays a role in
lysine catabolism where it metabolizes -aminoadipic semialde-
hyde (AASA) to -aminoadipic acid [7]. Lysine is an essential amino
acid and its metabolism is important for the maintenance of cellu-
lar nitrogen pools, synthesis of glutamate and formation of ketone
bodies [8]. Recently, the enzyme was also found to play a signifi-
cant role in protecting mammalian cells from hyperosmotic stress,
presumably through the generation of the osmolyte betaine from
betaine aldehyde [9]. The same study also identified that ALDH7A1
is enzymatically active against a number of lipid peroxidation-
derived aldehydes which are formed under oxidative conditions.
Hyperosmotic stress is coupled to the generation of reactive oxy-
gen species (ROS) and elevated oxidative stress within the cell [10].
The tight correlation between osmotic and oxidative stress suggests
that the cytoprotective functions of ALDH7A1 may be two fold: (1)
the generation of osmolytes to counteract osmotic stress and (2)
the removal of reactive aldehydes generated as a result of increased
oxidative stress.
ROS and lipoxidation products generated during oxidative stress
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adicals, superoxide and hydrogen peroxide (H2O2) are read-
ly formed during oxidative stress and can trigger the oxidative
egradation of biological membranes, known as lipid peroxida-
ion (LPO). LPO occurs when free radicals remove electrons from
ipids found within cellular membranes, preferentially attacking
olyunsaturated fatty acids (PUFAs) [11]. This process produces
atty acid radicals which in turn react with molecular oxygen to
orm lipid peroxyl radicals. The lipid peroxyl radicals then react
ith neighboring fatty acids to generate lipid peroxides and addi-
ional fatty acid radicals that initiate additional rounds of oxidation.
ntioxidants, such as vitamin E, or antioxidant enzymes, includ-
ng catalase, superoxide dismutase and peroxidases, can terminate
edox cycling by directly neutralizing radicals [12]. Aldehydes are
roduced in large quantities during LPO as a result of lipid chain
leavage and are considered secondary toxic metabolites [13,14].
PO produces over 200 different aldehydes, many of which are
ighly reactive and extremely toxic even at low concentrations.
f those produced, propanal, hexanal, MDA and 4HNE are the most
bundant [13,14]. Aldehydes can covalently bind to protein and
NA resulting in protein inactivation and DNA damage. Moreover,
ldehydes are associated with the pathophysiology of several dis-
ases including Parkinson’s disease, Alzheimer’s disease, cataract
ormation, atherosclerosis and alcoholic liver disease, to name a
ew [15–19]. As such, understanding the enzymes and pathways
ssociated with aldehyde removal has direct relevance to disease
revention and treatment.
The present studies were performed to determine the cyto-
rotective actions of ALDH7A1 during oxidative stress. More
pecifically, we examine whether ALDH7A1 can protect mam-
alian cells from oxidants, such as hydrogen peroxide, and toxic
PO-derived aldehydes.
. Materials and methods
.1. Materials
Lipofectamine Plus reagent and hygromycin B were purchased
rom Invitrogen (Carlsbad, CA). The affinity resin, 5′-AMP-
epharose 4B, used for fast protein liquid chromotography (FPLC)
as obtained from GE Healthcare (Piscataway, NJ). PVDF mem-
ranes were purchased from Millipore (Bedford, MA). Complete
rotease Inhibitor Cocktail tablets were obtained from Roche (Indi-
napolis, IN). Horseradish peroxidase-conjugated goat anti-rabbit
econdary antibodies were obtained from Jackson ImmunoRe-
earch Laboratories (West Grove, PA). Reagents for chemilumines-
ence were purchased from NEN Life Science Products (Boston,
A). Aldehyde substrates, NAD+, sodium pyrophosphate, sodium
hosphate, potassium phosphate and Amberlyst® 15 ion exchange
esin were purchased from Sigma–Aldrich (St. Louis, MO). Ally-
ine ethylene acetal was purchased from Chiralix (Nijmegen, The
etherlands). 4HNE was purchased from Cayman Chemical Com-
any (Ann Arbor, MI). Protein assay reagent was obtained from
ioRad (Hercules, CA). All chemicals were of analytical grade.
nless otherwise specified, all tissue-culture media, supplements,
ssay reagents and buffers were purchased from Invitrogen (Carls-
ad, CA) or Fisher Scientific (Hampton, NH).
.2. Cell cultureChinese hamster ovary (CHO) cells were grown in F-12 nutrient
edium (Ham’s) supplemented with 7% (vol/vol) heat-inactivated
etal bovine serum (HI-FBS), 20 mM HEPES (pH 7.4), penicillin
100 U/mL) and streptomycin (100 mg/mL) at 37 ◦C in a humidified
tmosphere containing 5% CO2.teractions 191 (2011) 269–277
2.3. Construction and expression of recombinant plasmids
Mammalian and baculovirus constructs were created using
human ALDH7A1 cDNA sequences and either pCEP4 or pBlue-
Bac4.5 expression vectors, respectively, as previously described
[9]. Both mitochondrial (pCEP4-ALDH7A1v1) and cytosolic
(pCEP4-ALDH7A1v2) ALDH7A1 coding sequences were cloned
into the pCEP4 expression vector. Baculovirus expression con-
structs were plaque-purified and amplified in Sf9 (Spodoptera
frugiperda) insect cells by the University of Colorado Cancer Center
Protein Production/MoAB/Tissue Culture Shared Core as described
previously [20,21].
2.4. Generation of ALDH7A1-transfected cell lines
Stable cell lines were created by transfecting cells with
either vector (pCEP4) or mitochondrial ALDH7A1 (pCEP4-
ALDH7A1v1) using Lipofectamine Plus reagent as previously
described [22]. Stable cell populations were then selected for in
media containing hygromycin B (0.4 mg/mL). ALDH7A1 expres-
sion was screened by Western blot. Two stable cell lines,
CHO-ALDH7A1v1 #14 and #35, were generated and the higher
expressing cell line (CHO-ALDH7A1v1 #35) was used in subse-
quent experiments to determine cytoprotection and LC50 values
towards various aldehydes (benzaldehyde, hexanal, octanal, 4HNE,
malondialdehyde (MDA) and AASA). Pooled populations of tran-
siently transfected cells were used in SRB assays to compare
protective effects of mitochondrial (ALDH7A1v1) and cytosolic
(ALDH7A1v2) variants against H2O2 and 4HNE. CHO cells were
transiently transfected in 100 mm dishes at 80% confluence using
Lipofectamine Plus reagent and pCEP4, pCEP4-ALDH7A1v1
or pCEP4-ALDH7A1v2 to create CHO-Vector, CHO-ALDH7A1v1
and CHO-ALDH7A1v2 cells, respectively. Western blotting was
then used to determine ALDH7A1 expression levels. These cells
were then used to seed multi-well plates for subsequent treat-
ments.
2.5. Western immunoblotting
Cell lysates were prepared using radio-immunoprecipitation
assay (RIPA) buffer (25 mM Tris–HCl (pH 7.6), 150 mM NaCl, 1%
NP-40, 1% sodium deoxycholate, 0.1% SDS) plus Complete Pro-
tease Inhibitor Cocktail. Cells were rocked at 4 ◦C with RIPA for
15 min then sonicated four times for 10 s. Crude lysates were
centrifuged at 15,000 rpm for 10 min to pellet debris and super-
natants transferred to a fresh microfuge tube. Lysates (20 g per
well) and recombinant ALDH7A1 (30 ng per well) were separated
by SDS–PAGE (12%). Analysis was performed as described pre-
viously using polyclonal anti-human ALDH7A1 antibody (1:5000
dilution) and horseradish peroxidase (HRP)-conjugated secondary
antibody at 1:5000 [9]. Protein concentrations were determined
using BioRad Protein Assay reagent according to the manufacturer’s
instructions. Densitometry was performed on the resulting West-
ern data using BioRad’s Quantity One (version 4.6.5) image analysis
software. The results represent the means ± standard deviation
from three separate experiments.
2.6. Aldehyde treatments
Unless otherwise stated, aldehyde substrates were obtained
from Sigma–Aldrich. AASA was generated from allysine ethy-
lene acetal as described previously [5]. The concentration of
AASA synthesized was determined by derivatization to 2-
aminobenzaldehyde followed by absorbance measurements at
465 nm [23].






























ig. 1. ALDH7A1 transgene expression in CHO cells. ALDH7A1 protein levels in bo
nalysis. 20 g cell lysates were ran per well. 30 ng recombinant human ALDH7A1
rotein levels between cell lines (B and D). ALDH7A1 protein levels were normali
eviation from three separate experiments (*p < 0.05).
The median lethal concentrations (LC50) for various aldehy-
es were established using CHO-Vector and CHO-ALDH7A1v1 #35
ell lines. Cells were plated in 96-well tissue culture plates and
oncentration response curves were determined for benzalde-
yde (0–20 mM), hexanal (0–20 mM), 4HNE (0–0.32 mM), MDA
0–40 mM) and octanal (0–2 mM) using MTT assays after a 1 h treat-
ent. Data were plotted and LC50 values were calculated for each
reatment. Results are presented as a mean ± standard deviation
rom nine different biological samples from three separate experi-
ents.
For 4HNE and H2O2 treatments, transiently transfected
HO-Vector, CHO-ALDH7A1v1 and CHO-ALDH7A1v2 cells were
rypsinized and counted with a hemacytometer. They were then
sed to seed 24-well plates at 2 × 105 cells per well in 1 mL
omplete growth media and left in the tissue culture incubator
vernight. The following day cell confluence was approximately
0%. The media was then carefully removed and replaced with var-
ous concentrations of 4HNE (0–100 M) or H2O2 (0–5 mM) in 1 mL
henol red-free DMEM containing 1% fetal bovine serum. Treated
ells were incubated for 16 h and images taken using a Nikon Eclipse
S100 inverted microscope equipped with a Nikon DS-Fi1 digital
amera (Nikon, Melville, NY). The dishes were then used for subse-
uent SRB assays. Results represent the combined data from twelve
ifferent samples from three separate experiments.
AASA cytotoxicity was determined using stable CHO-Vector and
HO-ALDH7A1v1 #35 cell lines. Cells were treated in 96-well tissue
ulture plates with increasing concentrations of AASA (0–10 mM)
or 24 h and assayed for mitochondrial function by MTT assay. Datably (A) and transiently (C) transfected cell lysates were analyzed by Western blot
cluded as a positive control (rALDH7A1). Densitometry was then used to compare
the respective -actin expression. Density is displayed as the means ± standard
are presented as a mean ± standard deviation from 27 different bio-
logical samples from three separate experiments. Cell viability is
expressed as percent untreated control.
2.7. MTT (3-(4,5-dimethylthiazolyl-2)-2, 5-diphenyltetrazolium
bromide) and SRB (sulforhodamine B) assays
MTT assays were performed as previously described [24]. For
SRB assays, 1 mL cold 10% trichloroacetic acid was added to the
media after aldehyde treatment. The plates were incubated for 1 h
at 4 ◦C then washed four times with water and allowed to dry
overnight at room temperature. The following day 0.5 mL 0.057%
(wt/vol) SRB in 1% (vol/vol) acetic acid was added to each well.
The plates were left at room temperature for 30 min, rinsed four
times with 1% (vol/vol) acetic acid to remove unbound dye then left
overnight at room temperature to dry. 1 mL of 10 mM Tris base (pH
10.5) was then added to each well and the plates were shaken for
15 min to dissolve bound dye. Fluorescence measurements were
taken at an excitation and emission wavelength of 488 nm and
570 nm, respectively, using a Spectramax Gemini EM platereader
(Molecular Devices, Sunnyvale, CA).
2.8. Protein purificationSF9 expressed recombinant human ALDH7A1 was purified via
FPLC using an AKITA (GE Health Sciences) equipped with a 5′-AMP-
Sepharose 4B affinity column. ALDH purification was performed
as previously described by us for other ALDH proteins including
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Fig. 2. Mitochondrial and cytosolic ALDH7A1 provide significant protection against hydrogen peroxide (H2O2)-induced cytotoxicity. CHO cells were transiently transfected
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ith either mitochondrial (CHO-ALDH7A1v1) (A) or cytosolic (CHO-ALDH7A1v2) (
0–5 mM) for 16 h and cell survival accessed using SRB assays. Vector transfections w
o untreated control (% untreated). Images of treated cells show significant protectio
ifference from vector control. Data represent means ± SD from triplicate assays (*p
LDH3A1 and ALDH1A1 [20,21]. Re-activation of purified recombi-
ant protein was accomplished by incubating the protein in 50 mM
ME for 30 min at room temperature prior to kinetic activity mea-
urements.
.9. ALDH enzymatic activity and kinetic studies
The enzymatic activity of ALDH7A1 was measured spec-
rophotometrically (Beckman, model DU-640, Fullerton, CA) by
onitoring the production of NADH at a wavelength of 340 nm
uring the oxidation of aldehydic substrates. Activity assays were
erformed in a 1 mL reaction mixture (25 ◦C) comprising 100 mM
odium pyrophosphate (pH 8.0), 5 mM BME, 1 mM NAD+, 1 mM
yrazole and 5 mg recombinant ALDH7A1 protein. The enzymatic
eaction was initiated by the addition of aldehydic substrates and
easurements were recorded every 5 s for 3 min. For 4HNE kinetic
tudies, ten substrate concentrations (0–5 mM) were assayed with
t least four concentrations both above and below the apparent Km.H7A1 expression constructs then treated with increasing concentrations of H2O2
sed as a negative control (CHO-Vector). Cell survival data was normalized in respect
e indicated concentrations (C). Asterisks immediately above bars denote significant
5; ***p < 0.001).
The resulting rates were fitted to the Michaelis–Menten equation
using SigmaPlot (version 7.0) software.
2.10. Data analysis
Data were expressed as mean ± standard deviation (SD). Differ-
ent data group comparisons were performed by Student’s unpaired
t-test. All data analyses including enzyme kinetics were carried out
using SigmaPlot (version 7.0) software. Observed differences were
regarded as significant at p < 0.05.
3. Results3.1. ALDH7A1 expression in CHO cells
Stable and transient expression of ALDH7A1 in CHO cells was
verified by Western blot (Fig. 1A and C). Expression levels in both
stable and transiently transfected cell lines were compared using
C. Brocker et al. / Chemico-Biological In
Table 1
LC50 values for toxic aldehydes in CHO-Vector and CHO-ALDH7A1v1 cell lines.
Control (CHO-Vector) and mitochondrial ALDH7A1 (CHO-ALDH7A1v1 #35) cell
lines were plated in 96-well tissue culture plates and treated with benzaldehyde
(0–20 mM), hexanal (0–20 mM), 4HNE (0–0.32 mM), MDA (0–40 mM) and octanal
(0–2 mM). MTT assays were performed after 1 h exposure. Median lethal concentra-
tion (LC50) values were determined using SigmaPlot software. Data are presented
as a mean ± standard deviation from nine different biological samples from three
separate experiments (***p < 0.001).
Treatment CHO-Vector CHO-ALDH7A1v1
Benzaldehyde 14.4 ± 0.44 15.1 ± 0.88
Hexanal 2.8 ± 0.08 7.1 ± 0.40***












































4-HNE 0.081 ± 0.003 0.125 ± 0.005***
MDA 37.3 ± 0.40 36.2 ± 0.43
*** p < 0.001.
ensitometry after being normalized to the respective -actin
ands (Fig. 1B and D). Results obtained indicated that the total
LDH7A1 protein levels were approximately 35% higher in CHO-
LDH7A1v1 #35 when compared to CHO-ALDH7A1v1 #14 cells.
he higher expressing cell line (CHO-ALDH7A1v1 #35) was used in
ubsequent treatment experiments. In transiently transfected cells,
ellular ALDH7A1 protein levels were approximately 20% higher in
he CHO-ALDH7A1v1 (mitochondrial) cells than the ALDH7A1v2
cytosolic) cell line. Mitochondrial and cytosolic subcellular local-
zation for the ALDH7A1 variants cloned into the given expression
ectors were characterized previously [9,25].
.2. ALDH7A1 mediated cytoprotection against reactive
ldehydes
CHO-Vector and CHO-ALDH7A1v1 #35 cells were treated with
ncreasing concentrations of benzaldehyde (0–20 mM), hexanal
0–20 mM), 4HNE (0–0.32 mM), MDA (0–40 mM) and octanal
0–2 mM). Following aldehyde treatment, MTT assays were per-
ormed to determine the ability of ALDH7A1 expression to protect
ells from cytotoxicity (Table 1). The calculated LC50 values for
HO-Vector treatments were 14.4 mM, 2.8 mM, 1.8 mM, 81 M
nd 37.3 mM for benzaldehyde, hexanal, octanal, 4HNE and MDA,
espectively. CHO-ALDH7A1v1 #35 cell treatments gave LC50
alues of 15.1 mM, 7.4 mM, 1.1 mM, 125 M, 36.2 mM for benzalde-
yde, hexanal, octanal, 4HNE and MDA, respectively. ALDH7A1
xpression provided significant protection (p < 0.001) against both
exanal and 4HNE. Significant protection was not observed in ben-
aldehyde, octanal or MDA treated cells.
.3. Mitochondrial and cytosolic ALDH7A1 expression in CHO
ells treated with H2O2 or 4HNE
CHO cells transiently transfected with either the mitochon-
rial (CHO-ALDH7A1v1) or cytosolic (CHO-ALDH7A1v2) forms of
uman ALDH7A1 were treated with increasing concentrations of
ither H2O2 (0–5 mM) (Fig. 2) or 4HNE (0–100 M) (Fig. 3). SRB
ssays were then used to analyze cell survival. CHO-Vector cells
xhibited comparable sensitivity to H2O2 as a number of cell
ines identified within the literature [26–31]. Significant protec-
ion (p < 0.001) was observed at 50 M, 100 M, 500 M and 1 mM
2O2 in cells expressing either the mitochondrial or cytosolic forms
f the protein (Fig. 2A and B). Significant protection (p < 0.05) was
lso observed at 5 mM in cell line expressing the cytosolic variant
Fig. 2B). The degree of protection was also evident in images taken
f the treated cells at the concentrations mentioned above (Fig. 2C).
Both cell lines were additionally treated with increasing con-
entrations of the reactive aldehyde 4HNE. Significant protection
as observed in cells expressing mitochondrial ALDH7A1 at 25 M
p < 0.001), 50 M (p < 0.001) and 100 M (p < 0.01) 4HNE (Fig. 3A).teractions 191 (2011) 269–277 273
The cytosolic variant also provided significant protection against
4HNE treatment at 25 M (p < 0.01), 50 M (p < 0.001) and 100 M
(p < 0.01) (Fig. 3B). Images of treated cells further support signifi-
cant protection at these concentrations (Fig. 3C).
The degree of protection conferred for mitochondrial and
cytosolic ALDH7A1 was also compared for each treatment. No
significant differences were noted between the H2O2 treated
cells at any concentrations. The mitochondrial variant provided
significantly more protection than cytosolic ALDH7A1 in cells
treated with 25 M (p < 0.001), 50 M (p < 0.01) and 100 M
(p < 0.01) 4HNE. However, transgene expression levels differ
slightly between the two cell populations making direct compar-
isons difficult.
3.4. ALDH7A1 cytoprotection against ˛-aminoadipic
semialdehyde (AASA) treatment
CHO cells stabily over expressing mitochondrial ALDH7A1
(CHO-ALDH7A1v1 #35) were treated with increasing concentra-
tions of the lysine degradation product AASA (0–10 mM) (Fig. 4).
MTT assays were then performed to determine aldehyde toxicity
and the ability of ALDH7A1 to attenuate these effects. It was dif-
ficult to determine an accurate LC50 value due to the limitations
in the maximum treatment concentrations of AASA after synthesis.
However, we were able to identify significant protection (p < 0.05)
at the two highest concentrations of AASA (5 and 10 mM).
3.5. Recombinant enzyme activity against 4-hydroxy-2-nonenal
(4HNE) and effect of activation with ˇ-mercaptoethanol (BME)
Previous studies have shown that many enzymes, including
mitochondrial ALDHs, are susceptible to oxidative inactivation. As
such, incubation with reducing agents such as dithiothreitol (DTT)
and BME can restore catalytic activity [22,32–35]. The effect of BME
incubation on ALDH7A1 activity was analyzed using propanal as a
substrate. In previous studies ALDH7A1 exhibited a Km and Vmax
of 647.4 M and 69.9 nmol NADH/min/mg, respectively, towards
this substrate [36]. Incubating recombinant ALDH7A1 with BME
prior to measuring enzymatic activity resulted in an approxi-
mately four fold increase in the initial reaction velocity (V0) at
all propanal concentrations used (0.25, 0.75 and 1.0 mM) when
compared to non-activated samples (Fig. 5). Non-activated, recom-
binant human ALDH7A1 did not exhibit activity towards 4HNE.
However, activation of recombinant enzyme with BME restored
activity towards the substrate. A Km of 119.5 ± 16.8 M, Vmax of
323.5 ± 13.4 nM/min/mg and Km/Vmax of 2.71 were determined for
4HNE by monitoring the production of NADH at a wavelength of
340 nm.
4. Discussion
Mitochondrial ALDH7A1 was previously shown to protect mam-
malian cells against hyperosmotic stress [9]. Herein, we report
additional cytoprotective functions for ALDH7A1 against oxidative
stress and LPO-derived aldehydes. Reactive oxygen species (ROS)
production is an unavoidable consequence of aerobic metabolism.
Hydrogen peroxide (H2O2) is an uncharged, relatively stable and
freely diffusible ROS. The compound is generated physiologically
during mitochondrial respiration predominantly by superoxide
dismutase (SOD) [37]. Many other enzymes, including monoamine
oxidases (MAOs) and nicotinamide adenine dinucleotide phos-
phate (NADPH) oxidases, also contribute to H2O2 production.
Elevated H2O2 within cells and tissues can have a variety of patho-
logical consequences. H2O2 can be converted to highly reactive
hydroxyl radicals (OH•) which can then attack DNA, proteins and
lipids resulting in enzyme inactivation, DNA strand breakage and
274 C. Brocker et al. / Chemico-Biological Interactions 191 (2011) 269–277
Fig. 3. Mitochondrial and cytosolic ALDH7A1 provide significant protection against 4-hydroxy-2-nonenal (4HNE)-induced cytotoxicity. CHO cells were transiently transfected
with either mitochondrial (CHO-ALDH7A1v1) (A) or cytosolic (CHO-ALDH7A1v2) (B) ALDH7A1 expression constructs then treated with increasing concentrations of 4HNE





















he effect of this vehicle. Cell survival data was normalized in respect to untrea
ndicated concentrations (C). Asterisks immediately above bars denote significant di
**p < 0.001).
ipid peroxidation, respectively. Lipid peroxidation (LPO) describes
he oxidative degradation of biological membranes. LPO is self-
erpetuating process and produces over 200 types of aldehydes
38]. Many LPO-derived aldehydes can covalently bind, or adduct,
iological macromolecules including DNA, proteins and lipids [13].
imilar to the damage caused by hydroxyl radicals, LPO aldehyde
dduction can inactivate enzymes and damage chromosomal DNA.
urthermore, aldehydes are potent electrophiles that readily bind
lutathione (GSH). As oxidative stress persists, cellular GSH pools
re depleted and intracellular redox balance becomes impaired.
nhindered, the combined effects of hydroxyl radicals and LPO-
erived aldehydes can significantly upset cellular homeostasiseading to cell death and tissue damage. The ALDH7A1-mediated
emoval of LPO-derived aldehydes could therefore represent an
dditional cytoprotective mechanism by which the cell preserves
lutathione pools counteracting the damaging effects of oxida-
ive stress. Overexpression of mitochondrial ALDH7A1 in CHO cellsntrol (% untreated). Images of treated cells support significant protection at the
ce from vector control. Data represent means ± SD from triplicate assays (**p < 0.01;
(CHO-ALDH7A1v1) provided protection against the reactive alde-
hydes hexanal and 4HNE. CHO-Vector and CHO-ALDH7A1v1 cell
lines were treated with increasing concentrations of benzalde-
hyde, hexanal, octanal, 4HNE and MDA. Following treatment, MTT
assays were used to calculate LC50 values for each treatment in the
two cell lines. Hexanal treated CHO-Vector and CHO-ALDH7A1v1
cell lines exhibited LC50 values of 2.8 mM and 7.1 mM, respec-
tively. Similar results were observed in cells treated with 4HNE.
Calculated LC50 values for CHO-Vector and CHO-ALDH7A1v1 cell
lines were 81 M and 125 M 4HNE, respectively. These data were
somewhat surprising seeing how previous studies did not identify
activity towards this substrate [39]. Protection was not found in
cells treated with the aromatic aldehyde benzaldehyde or the three
carbon dialdehyde MDA, which was not unexpected seeing how the
enzyme was previously shown to have either very low affinity or no
activity towards these substrates [9,39]. Surprisingly, we also did
not see protection in octanal treated cells. Octanal is a high affinity

































































Fig. 4. Mitochondrial ALDH7A1 expression provides significant protection against
-aminoadipic semialdehyde (AASA)-induced cytotoxicity. CHO cells stably
transfected with either vector (CHO-Vector) or mitochondrial ALDH7A1 (CHO-
ALDH7A1v1 #35) were treated in 96-well tissue culture plates with various
concentrations of AASA (0–10 mM) for 24 h and assayed for mitochondrial func-
(PLP), or vitamin B6, resulting in severe vitamin B6 deficiency. In
tissues the levels of free lysine are reported to be approximately
1000 M, 650 M and 200 M in muscle, liver and plasma, respec-
tively [49–51]. This suggests that even under conditions highlyC. Brocker et al. / Chemico-Biolog
ubstrate for ALDH7A1 and previous studies revealed that the Km
or octanal is significantly lower than the Km for hexanal, 17.5 M
s. 39.1 M, respectively [9]. Despite a lower Km, the calculated
max for octanal was over three fold less than hexanal resulting
n a overall lower catalytic efficiency towards the substrate when
ompared to hexanal, which may explain the observed difference
n protection [9].
A mitochondrial (ALDH7A1v1) and cytosolic (ALDH7A1v2) form
f human ALDH7A1 have been identified [9,25]. Furthermore,
istinct localization patterns suggest that the enzyme may be asso-
iated with different pathways and, therefore, substrates within
pecific cell-types and tissues. To shed light on whether subcellu-
ar localization influences protection, CHO cells were transfected
ith either mitochondrial or cytosolic ALDH7A1 then treated with
ncreasing concentrations of H2O2 and 4HNE. Following treatment,
RB assays were performed to determine cell survival. Results
rom these experiments revealed that both the mitochondrial and
ytosolic variants confer significant protection against these toxic
ompounds. There was no significant difference in the degree of
rotection noted between the mitochondrial and cytosolic protein
xpressing cell lines treated with H2O2. Interestingly, a signifi-
ant difference in overall protection was observed between the
wo ALDH7A1 expressing cell lines treated with 4HNE. How-
ver, subsequent densitometry analyses indicated higher transgene
xpression in the mitochondrial cell line, which could account for
he observed experimental differences. Nevertheless, it is interest-
ng to postulate that subcellular localization could have differential
ffects on cytoprotection depending on insult type.
The linear aliphatic aldehyde hexanal and the , -unsaturated
ldehyde 4HNE are two of the predominant aldehydes generated
uring LPO [13,14]. These studies reveal that ALDH7A1 provides
ignificant protection against both compounds. Under normal
hysiological conditions, the basal levels of 4HNE are very low
<1 M) [13]. However, 4HNE concentrations vary greatly, espe-
ially during oxidative stress where concentrations can increase
ignificantly. Hexanal does not exhibit the same toxicity as 4HNE
ut concentrations were shown to be approximately nine fold
igher than 4HNE under various types of stress [14]. Moreover,
HNE and other lipoxidation product levels increase with proxim-
ty to lipid membranes, which are the major site of synthesis. The
oncentration of 4HNE within the lipid membranes of peroxidised
icrosomes were calculated to be approximately 4.5 mM [40]. Fur-
hermore, the average half-life of 4HNE is approximately 2 min, as
uch, it is capable of diffusing significant distances, in effect, estab-
ishing a concentration gradient from the site of production [13].
revious studies looking at the seabream fish ALHD7A1 did not
etect activity towards 4HNE [39]. However, the range of 4HNE
oncentrations used in the assay was 1–32 mM. At these concen-
rations there is a high likelihood that 4HNE would completely
nactivate the enzyme. The calculated Km of human ALDH7A1
owards 4HNE was 119.5 M. This value does not strongly sup-
ort a catalytic function under physiological conditions. Moreover,
elated ALDH superfamily members metabolize 4HNE with much
igher affinity, including mitochondrial ALDH2 which exhibits Km
nd Vmax values of 14.3 M and 3.5 nmol/min/mg, respectively
41,42]. Interestingly, many LPO-derived aldehydes such as 4HNE,
crolein, crotonaldehyde and MDA are known to inhibit alde-
yde dehydrogenase activity [43–46]. 4HNE has been shown to
eversibly inhibit ALDH2 and at high concentrations (>50 M) the
nzyme is completely inactivated [47]. It is therefore reasonable to
ostulate that as 4HNE concentrations increase to levels that inhibitow Km enzymes, such as ALDH2, ALDH7A1 and other high Km ALDH
nzymes might then play an important role in metabolizing this
ytotoxic compound. To date, ALDH7A1 is unique among ALDH
nzymes in that it is expressed at high levels in multiple subcellu-
ar compartments including the mitochondria, cytosol and nucleustion by MTT assay. Cell viability data was normalized in respect to untreated control
(% untreated). Asterisks immediately above bars denote significant difference from
vector control. Data are presented as a mean ± standard deviation from 27 different
biological samples from three separate experiments (*p < 0.05).
[9,25]. Given the high concentrations and widespread distribution
of 4HNE, the extensive subcellular localization of ALDH7A1 further
supports a potentially important pathophysiological role for 4HNE
metabolism in response to pro-oxidant exposure.
The lysine catabolite, AASA, is thought to be a major physiologi-
cal substrate for mammalian ALDH7A1. To date, very little is known
about the inherent toxicity associated with this aldehyde. Our data
indicates that AASA was only mildly toxic at relatively high concen-
trations. The physiological concentration of this aldehyde within
tissues in not known. However, the levels in human plasma are
reported to be less than 0.2 M [48]. In patients with null mutations
in ALDH7A1 reported plasma AASA concentrations are between 0.5
and 14 M [48]. At these levels it does not appear the aldehyde itself
exhibit toxicity. However, in pyridoxine-dependent epilepsy (PDE)
the pathophysiology of increased AASA concentrations is believed
to manifest via the conjugation of AASA to pyridoxal phosphateFig. 5. ALDH7A1 activity is sensitive to oxidation. Incubation of ALDH7A1 with the
reducing agent BME restores catalytic activity. In vitro activity assays with recom-
binant human protein revealed an approximately 4 fold increase in initial velocity
(V0) at all propanal concentrations (0.25 mM, 0.75 mM & 1.0 mM) tested when com-
pared to non-activated enzyme. Asterisks immediately above bars denote significant
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avoring lysine oxidation to AASA the concentrations would prob-
bly not raise to toxic levels (i.e. >5 mM).
Intracellular redox state and oxidative stress are known to sig-
ificantly affect enzyme activity [52]. Loss of enzyme activity as
result of protein oxidation in many cases can be reversed with
thiol reducing agent, such as BME, which restores sulfhydryl
roups [32–34]. The substantial increase in ALDH7A1 catalytic
ctivity after incubation with BME suggests the enzyme is sen-
itive to oxidation. Moreover, recombinant ALDH7A1 was unable
o metabolize 4HNE without prior activation with the reducing
gent. Oxidants such as H2O2 are known to significantly inhibit
rythrocyte aldehyde dehydrogenase I activity [53]. This implies
hat as oxidative stress increases within the cell the activity and
ubstrate specificity of ALDH7A1 may be significantly altered. In
revious studies, it was hypothesized that human ALDH7A1 plays
n important protective role during hyperosmotic stress presum-
bly through the generation of the cellular osmolyte betaine from
etaine aldehyde [9]. The study also identified that ALDH7A1 is
apable of metabolizing a number of known LPO-derived aldehy-
es, suggesting a role for ALDH7A1 during cellular defense against
xidative stress. The current study expands upon these findings and
onfirms that ALDH7A1 enzyme activity is cytoprotective under
xidative conditions where LPO and subsequent aldehyde levels are
levated. Mechanistically, the removal of LPO-derived aldehydes
y ALDH7A1 could have multiple cytoprotective functions. By low-
ring aldehyde concentrations within the cell, ALDH7A1 metabolic
ctivity should reduce the need for GSH conjugation and help main-
ain intracellular GSH levels. Moreover, the ALDH7A1 mediated
emoval of reactive aldehydes, such as hexanal and 4-HNE, may
ower the extent of macromolecule adduction thereby lessening
athogenic consequences associated with enzyme inactivation. In
onclusion, data obtained from these studies supports an important
ole for ALDH7A1 in protecting cells from the damaging effects of
xidative stress and future studies are needed to elucidate the exact
echanisms underlying these observations.
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